Science
Mechanism of Action
This extract operates through a triple-pathway mechanism: it inhibits tyrosinase activity to prevent melanin synthesis, suppresses the NF-κB and MAPK signaling pathways to reduce pro-inflammatory cytokines (TNF-α and IL-1β), and utilizes sesquiterpenoid compounds like atractylon to scavenge reactive oxygen species (ROS).
Research
Clinical Evidence
Medium confidence2%
Key findings
- 01 In-vitro studies at 0.005% demonstrated a 68% inhibition of melanin when combined with Salvia hispanica.
- 02 Clinical evaluations of 1-5% concentrations in luxury Korean formulations showed a 22.9% increase in skin hydration and a 25.2% reduction in melanin synthesis indicators.
Transparency
Dusting Analysis
While potent in-vitro synergy occurs at very low levels, the threshold for visible improvements in moisture and hyperpigmentation in clinical settings is typically 1% or higher. Many mass-market formulations include it at 'label claim' levels below 0.1%.
The Formula
Formulation
Stability
Highly stable in aqueous and hydro-glycolic systems, though its volatile sesquiterpenes are prone to autoxidation if exposed to excessive air; airless packaging is recommended.
Synergies
- Salvia hispanica
- Niacinamide
- Hyaluronic Acid
Conflicts
- Strong oxidizing agents
- Formulations with pH <4.0 or >8.0
Safety
Safety Profile
Classified as GRAS (Generally Recognized as Safe) in food applications and has a long-standing history of use in high-end topical skincare without reported irritation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance botanical for targeting pigment and inflammation simultaneously, though it must be used at concentrations above 1% to maximize clinical outcomes.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources